Key Takeaways
- • SK IE Technology raised 300 billion won ($258 million) in a pre-IPO placement with Premier Partners at 47,816 won per share, reducing SK Innovation's stake from 100% to 90% and positioning the battery separator manufacturer for a 2025 public listing.
- • The IPO achieved record-breaking demand with a 1,883-to-1 competition ratio and 2.417 trillion won in total bids—the highest in South Korean IPO history, surpassing SK Bioscience's previous record of 1,275-to-1 and reflecting institutional appetite for EV battery materials exposure.
- • SK IE Technology priced its IPO at 105,000 won per share (the top end of the 78,000–105,000 won range) and raised approximately 2.25 trillion won by floating 21.4 million shares, with SK Innovation securing 1.35 trillion won in operating funds from the 22.7% stake sale.
- • The company aims to become the world's largest EV battery separator supplier, with production plants scheduled in China (Q4 2024 operational), Poland (2025 completion), and capacity investments aligned with the expanding global EV market.
- • Concentrated institutional investor participation marked the block trade exit, with the top five investors capturing 66% of shares and the top 10 investors receiving 80%, reflecting typical hedge fund and PE fund concentration in Korean equity capital markets.
Summary
SK IE Technology, the wholly owned lithium-ion battery separator subsidiary of SK Innovation, executed a successful pre-IPO capital raise of 300 billion won ($258 million) with Premier Partners, a domestic private equity fund, at 47,816 won per share. The transaction involved the issuance of 6.27 million new common shares representing 10% of total shares, reducing SK Innovation's ownership stake to 90% while positioning the company for a full public listing in 2025. The pre-IPO was designed to secure growth capital as the global EV battery market accelerates.
Following the pre-IPO placement, SK IE Technology's full IPO generated unprecedented demand across Korean capital markets. The two-day book building process attracted 1,734 domestic and foreign institutional investors, resulting in a 1,883-to-1 competition ratio—the most competitive IPO book building in South Korean history and surpassing SK Bioscience's record of 1,275-to-1 set the previous month. Total bids reached 2.417 trillion won, more than double SK Bioscience's record of 1.047 trillion won. The final IPO price was set at 105,000 won per share, the top end of the 78,000–105,000 won indicative range, allowing the company to raise approximately 2.25 trillion won by floating 21.4 million shares on Kospi. SK Innovation realized 1.35 trillion won in proceeds from its 22.7% stake reduction.
The block trade exit showed characteristic concentration among large institutional investors, with the top five investors capturing 66% of allocated shares and the top 10 receiving 80%, reflecting typical PE and hedge fund participation patterns in Korean capital markets. Post-IPO trading saw the stock debut at 159,500 won, representing a 52% premium to the IPO price, though gains subsequently pared as broader market sentiment weakened.
SK IE Technology's capital raise supports its stated strategy to become the world's largest EV battery separator supplier. The company is building production facilities in China (scheduled operational Q4 2024) and Poland (completion in 2025) to serve accelerating global EV demand. SK Innovation, the parent company, is simultaneously executing a broader EV battery strategy, targeting top-three global positioning by 2025 and planning to increase annual EV battery production capacity from 4.7 GWh to 100 GWh—an expansion requiring over 6 trillion won in total investment.
Following the pre-IPO placement, SK IE Technology's full IPO generated unprecedented demand across Korean capital markets. The two-day book building process attracted 1,734 domestic and foreign institutional investors, resulting in a 1,883-to-1 competition ratio—the most competitive IPO book building in South Korean history and surpassing SK Bioscience's record of 1,275-to-1 set the previous month. Total bids reached 2.417 trillion won, more than double SK Bioscience's record of 1.047 trillion won. The final IPO price was set at 105,000 won per share, the top end of the 78,000–105,000 won indicative range, allowing the company to raise approximately 2.25 trillion won by floating 21.4 million shares on Kospi. SK Innovation realized 1.35 trillion won in proceeds from its 22.7% stake reduction.
The block trade exit showed characteristic concentration among large institutional investors, with the top five investors capturing 66% of allocated shares and the top 10 receiving 80%, reflecting typical PE and hedge fund participation patterns in Korean capital markets. Post-IPO trading saw the stock debut at 159,500 won, representing a 52% premium to the IPO price, though gains subsequently pared as broader market sentiment weakened.
SK IE Technology's capital raise supports its stated strategy to become the world's largest EV battery separator supplier. The company is building production facilities in China (scheduled operational Q4 2024) and Poland (completion in 2025) to serve accelerating global EV demand. SK Innovation, the parent company, is simultaneously executing a broader EV battery strategy, targeting top-three global positioning by 2025 and planning to increase annual EV battery production capacity from 4.7 GWh to 100 GWh—an expansion requiring over 6 trillion won in total investment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.